What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?

Mark Speakman (1) , Jean-Nicolas Cornu (2, 3, 4, 5) , Mauro Gacci (6) , Christian Gratzke (7) , Charalampos Mamoulakis (8) , Thomas R.W. Herrmann (9, 10) , Muhammad Imran Omar (11) , Malte Rieken (12) , Kari A.O. Tikkinen (13) , Stavros Gravas (14)

1 Taunton & Somerset Hospital, Taunton, UK
2 Service d'urologie [Rouen]
3 ADEN - Nutrition, inflammation et dysfonctionnement de l'axe intestin-cerveau
4 IRIB - Institute for Research and Innovation in Biomedicine
5 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
6 UniFI - Università degli Studi di Firenze = University of Florence
7 Department of Urology, Albert-Ludwigs-University, Freiburg, Germany.
8 Department of Urology, University General Hospital of Heraklion, University of Crete Medical School, Heraklion, Crete, Greece.
9 Urology Clinic, Spital Thurgau AG, Frauenfeld, Switzerland
10 Department of Urology and Urological Oncology, Hanover Medical School, Hanover, Germany.
11 Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland, UK.
12 University Hospital Basel [Basel]
13 Helsingin yliopisto = Helsingfors universitet = University of Helsinki
14 Department of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Domains: Urology and Nephrology

Mark Speakman, Jean-Nicolas Cornu, Mauro Gacci, Christian Gratzke, Charalampos Mamoulakis, et al.. What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?. European Urology Focus, 2019, 5 (3), pp.351-356. ⟨10.1016/j.euf.2019.05.014⟩. ⟨hal-02473861⟩